Funded Tech Companies
MAP Pharmaceuticals
MAP Pharmaceuticals, operating out of Mountain View, received equity investments through D. E. Shaw Group, Perseus and Bay City Capital.
Company Overview
Company Name
MAP Pharmaceuticals
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
2400 Bayshore Parkway 200
Mountain View, CA 94043
USA
Mountain View, CA 94043
USA
Phone
Website
Email Address
Company Background Information
Overview
MAP is currently developing the proprietary Tempo Inhaler platform, a next-generation pressurized metered-dose inhaler (pMDI) that is designed for the pulmonary delivery of respiratory and systemic drug therapies.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/8/2007
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Timothy Nelson
Chief Financial Officer
Christopher Chai
Chief Scientific Officer
Thomas Armer
VP - Bus. Development
Anastasios Gianakakos
VP - General Counsel
Charlene Friedman
VP - General Counsel
Thomas McCracken
VP - Human Resources
Marco Rosa
VP - Manufacturing
Alan Petro
VP - Operations
Frederick Graff
Company Investors
- D. E. Shaw Group
- Perseus (Steven Elms)
- Bay City Capital (Carl Goldfischer)
- Skyline Ventures (John Freund)
- FirstMark Capital (Patrick Enright)
Browse more funded tech companies:
Share this article
About Our VC Deals Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs